{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:44Z","timestamp":1792788104080,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Beijing University of Chinese Medicine Independent Research Project for Graduate Students","award":["ZJKT2024024"],"award-info":[{"award-number":["ZJKT2024024"]}],"id":[{"id":"https:\/\/ror.org\/05damtm70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No. 7252235"],"award-info":[{"award-number":["No. 7252235"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["No.7254499"],"award-info":[{"award-number":["No.7254499"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Young Elite Scientists Sponsorship Program of the Beijing High Innovation Plan","award":["No. 20250706"],"award-info":[{"award-number":["No. 20250706"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"DOI":"10.1186\/s13020-026-01490-1","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:42:22Z","timestamp":1789958542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FuTCM-PDD: a multi-level information fusion framework integrating KAN modeling and AutoML for phenotype-based drug discovery from Traditional Chinese Medicine"],"prefix":"10.1186","volume":"21","author":[{"given":"Zewen","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"1490_CR1","doi-asserted-by":"crossref","unstructured":"Wang S, Wang Z, Fang L, Lv Y, Du G. Advances of the target-based and phenotypic screenings and strategies in drug discovery. Int J Drug Discov Pharmacol. 2022;2\u20132.","DOI":"10.53941\/ijddp.v1i1.199"},{"key":"1490_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","volume":"11","author":"JW Scannell","year":"2012","unstructured":"Scannell JW, Blanckley A, Boldon H, Warrington B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov. 2012;11:191\u2013200.","journal-title":"Nat Rev Drug Discov"},{"key":"1490_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/s41573-022-00472-w","volume":"21","author":"F Vincent","year":"2022","unstructured":"Vincent F, Nueda A, Lee J, Schenone M, Prunotto M, Mercola M. Phenotypic drug discovery: recent successes, lessons learned and new directions. Nat Rev Drug Discov. 2022;21:899\u2013914.","journal-title":"Nat Rev Drug Discov"},{"key":"1490_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrd.2017.111","volume":"16","author":"JG Moffat","year":"2017","unstructured":"Moffat JG, Vincent F, Lee JA, Eder J, Prunotto M. Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov. 2017;16:531\u201343.","journal-title":"Nat Rev Drug Discov"},{"key":"1490_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008;320:330\u20134.","journal-title":"Science"},{"key":"1490_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/bmj.1.4030.713","volume":"1","author":"J Gaddum","year":"1938","unstructured":"Gaddum J. Ephedrine. BMJ. 1938;1:713.","journal-title":"BMJ"},{"key":"1490_CR7","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med. 1995;332:1004\u201314.","journal-title":"N Engl J Med"},{"key":"1490_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/aps.2015.8","volume":"36","author":"J-h Zhang","year":"2015","unstructured":"Zhang J-h, Zhu Y, Fan X-h, Zhang B-l. Efficacy-oriented compatibility for component-based Chinese medicine. Acta Pharmacol Sin. 2015;36:654\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"1490_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154155","volume":"102","author":"Y Ren","year":"2022","unstructured":"Ren Y, Gao F, Li B, Yuan A, Zheng L, Zhang Y. A precise efficacy determination strategy of traditional Chinese herbs based on Q-markers: anticancer efficacy of Astragali radix as a case. Phytomedicine. 2022;102:154155.","journal-title":"Phytomedicine"},{"key":"1490_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh0215","volume":"9","author":"X Gan","year":"2023","unstructured":"Gan X, Shu Z, Wang X, Yan D, Li J, Ofaim S, et al. Network medicine framework reveals generic herb-symptom effectiveness of traditional Chinese medicine. Sci Adv. 2023;9:eadh0215.","journal-title":"Sci Adv"},{"key":"1490_CR11","doi-asserted-by":"publisher","first-page":"D1110","DOI":"10.1093\/nar\/gky1021","volume":"47","author":"Y Wu","year":"2019","unstructured":"Wu Y, Zhang F, Yang K, Fang S, Bu D, Li H, et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res. 2019;47:D1110\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1490_CR12","doi-asserted-by":"publisher","first-page":"D1238","DOI":"10.1093\/nar\/gkab1011","volume":"50","author":"D Yan","year":"2022","unstructured":"Yan D, Zheng G, Wang C, Chen Z, Mao T, Gao J, et al. HIT 2.0: an enhanced platform for herbal ingredients\u2019 targets. Nucleic Acids Res. 2022;50:D1238\u201343.","journal-title":"Nucleic Acids Res"},{"key":"1490_CR13","first-page":"18","volume":"7","author":"Y-f Liu","year":"2015","unstructured":"Liu Y-f, Ai N, Keys A, Fan X-h, Chen M-j. Network pharmacology for traditional Chinese medicine research: methodologies and applications. Chin Herb Med. 2015;7:18\u201326.","journal-title":"Chin Herb Med"},{"key":"1490_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-6-13","author":"JL Ru","year":"2014","unstructured":"Ru JL, Li P, Wang JN, Zhou W, Li BH, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014. https:\/\/doi.org\/10.1186\/1758-2946-6-13.","journal-title":"J Cheminform"},{"key":"1490_CR15","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.apsb.2023.03.012","volume":"13","author":"YQ Zhang","year":"2023","unstructured":"Zhang YQ, Li X, Shi YL, Chen T, Xu ZJ, Wang P, et al. ETCM v2.0: an update with comprehensive resource and rich annotations for traditional Chinese medicine. Acta Pharm Sin B. 2023;13:2559\u201371.","journal-title":"Acta Pharm Sin B"},{"key":"1490_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.ade2574","volume":"379","author":"Z Lin","year":"2023","unstructured":"Lin Z, Akin H, Rao R, Hie B, Zhu Z, Lu W, et al. Evolutionary-scale prediction of atomic-level protein structure with a language model. Science. 2023;379:1123\u201330.","journal-title":"Science"},{"key":"1490_CR17","unstructured":"Liu Z, Wang Y, Vaidya S, Ruehle F, Halverson J, Solja\u010di\u0107 M, Hou TY, Tegmark M. KAN. Kolmogorov-arnold networks. arXiv preprint arXiv:240419756 2024. 2025."},{"key":"1490_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-016-0977-x","volume":"17","author":"H \u00d6zt\u00fcrk","year":"2016","unstructured":"\u00d6zt\u00fcrk H, Ozkirimli E, \u00d6zg\u00fcr A. A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction. BMC Bioinformatics. 2016;17:128.","journal-title":"BMC Bioinformatics"},{"key":"1490_CR19","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk H, \u00d6zg\u00fcr A, Ozkirimli E. DeepDTA: deep drug\u2013target binding affinity prediction. Bioinformatics. 2018;34:i821\u20139.","journal-title":"Bioinformatics"},{"key":"1490_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/cmb.2010.0213","volume":"18","author":"L Perlman","year":"2011","unstructured":"Perlman L, Gottlieb A, Atias N, Ruppin E, Sharan R. Combining drug and gene similarity measures for drug-target elucidation. J Comput Biol. 2011;18:133\u201345.","journal-title":"J Comput Biol"},{"key":"1490_CR21","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1093\/bioinformatics\/btr500","volume":"27","author":"T van Laarhoven","year":"2011","unstructured":"van Laarhoven T, Nabuurs SB, Marchiori E. Gaussian interaction profile kernels for predicting drug\u2013target interaction. Bioinformatics. 2011;27:3036\u201343.","journal-title":"Bioinformatics"},{"key":"1490_CR22","first-page":"68","volume":"15","author":"JH Wang","year":"2020","unstructured":"Wang JH, Wang H, Wang XD, Chang HY. Predicting drug-target interactions via FM-DNN learning. Curr Bioinform. 2020;15:68\u201376.","journal-title":"Curr Bioinform"},{"key":"1490_CR23","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","volume":"37","author":"T Nguyen","year":"2020","unstructured":"Nguyen T, Le H, Quinn TP, Nguyen T, Le TD, Venkatesh S. GraphDTA: predicting drug\u2013target binding affinity with graph neural networks. Bioinformatics. 2020;37:1140\u20137.","journal-title":"Bioinformatics"},{"key":"1490_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108878","volume":"179","author":"Z Wang","year":"2024","unstructured":"Wang Z, Huo M, Qiao L, Qiao Y, Zhang Y. SYSTCM: a systemic web platform for objective identification of pharmacological effects based on interplay of \u201ctraditional Chinese medicine-components-targets.\u201d Comput Biol Med. 2024;179:108878.","journal-title":"Comput Biol Med"},{"issue":"8","key":"1490_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1145\/3470918","volume":"54","author":"SK Karmaker","year":"2021","unstructured":"Karmaker SK, Hassan MM, Smith MJ, Xu L, Zhai CX, Veeramachaneni K. AutoML to date and beyond: challenges and opportunities. Acm Comput Surv. 2021;54(8):1\u201336.","journal-title":"Acm Comput Surv"},{"key":"1490_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27137-3","volume":"12","author":"Q Ye","year":"2021","unstructured":"Ye Q, Hsieh C-Y, Yang Z, Kang Y, Chen J, Cao D, et al. A unified drug\u2013target interaction prediction framework based on knowledge graph and recommendation system. Nat Commun. 2021;12:6775.","journal-title":"Nat Commun"},{"key":"1490_CR27","doi-asserted-by":"crossref","unstructured":"Quadrianto N, Smola AJ, Caetano TS, Le QV. Estimating labels from label proportions. In Proc. 25th International Conference on Machine learning. 2008;776\u2013783.","DOI":"10.1145\/1390156.1390254"},{"key":"1490_CR28","unstructured":"Havaldar S, Sharma N, Sareen S, Shanmugam K, Raghuveer A: Learning from label proportions: bootstrapping supervised learners via belief propagation. In International Conference on Learning Representations. 2024: 20596\u201320619."},{"key":"1490_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007249","volume":"15","author":"Y Wang","year":"2019","unstructured":"Wang Y, Jafari M, Tang Y, Tang J. Predicting meridian in Chinese traditional medicine using machine learning approaches. PLoS Comput Biol. 2019;15:e1007249.","journal-title":"PLoS Comput Biol"},{"key":"1490_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01339-1","volume":"8","author":"Q Lv","year":"2023","unstructured":"Lv Q, Chen G, He H, Yang Z, Zhao L, Zhang K, et al. TCMBank-the largest TCM database provides deep learning-based Chinese-Western medicine exclusion prediction. Signal Transduct Target Ther. 2023;8:127.","journal-title":"Signal Transduct Target Ther"},{"key":"1490_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf474","author":"J Shan","year":"2025","unstructured":"Shan J, Sun J, Zheng H. MIF\u2013DTI: a multimodal information fusion method for drug\u2013target interaction prediction. Brief Bioinform. 2025. https:\/\/doi.org\/10.1093\/bib\/bbaf474.","journal-title":"Brief Bioinform"},{"key":"1490_CR32","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/bioinformatics\/btab715","volume":"38","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Zhao H, Zheng K, Wang J. HyperAttentionDTI: improving drug\u2013protein interaction prediction by sequence-based deep learning with attention mechanism. Bioinformatics. 2022;38:655\u201362.","journal-title":"Bioinformatics"},{"key":"1490_CR33","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00127","volume-title":"Discovery of a cyclic boronic acid \u03b2-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases","author":"SJ Hecker","year":"2015","unstructured":"Hecker SJ, Reddy KR, Totrov M, Hirst GC, Lomovskaya O, Griffith DC, et al. Discovery of a cyclic boronic acid \u03b2-lactamase inhibitor (RPX7009) with utility vs class A serine carbapenemases. ACS Publications; 2015."},{"key":"1490_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.str.2005.11.019","volume":"14","author":"M Groll","year":"2006","unstructured":"Groll M, Berkers CR, Ploegh HL, Ovaa H. Crystal structure of the boronic acid-based proteasome inhibitor bortezomib in complex with the yeast 20S proteasome. Structure. 2006;14:451\u20136.","journal-title":"Structure"},{"key":"1490_CR35","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nsb0697-490","volume":"4","author":"A Achari","year":"1997","unstructured":"Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol. 1997;4:490\u20137.","journal-title":"Nat Struct Biol"},{"key":"1490_CR36","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1021\/bi1003298","volume":"49","author":"RS Sidhu","year":"2010","unstructured":"Sidhu RS, Lee JY, Yuan C, Smith WL. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers. Biochemistry. 2010;49:7069\u201379.","journal-title":"Biochemistry"},{"key":"1490_CR37","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.biopha.2017.07.068","volume":"93","author":"B Bie","year":"2017","unstructured":"Bie B, Sun J, Guo Y, Li J, Jiang W, Yang J, et al. Baicalein: a review of its anti-cancer effects and mechanisms in hepatocellular carcinoma. Biomed Pharmacother. 2017;93:1285\u201391.","journal-title":"Biomed Pharmacother"},{"key":"1490_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.canlet.2014.08.003","volume":"354","author":"H Chen","year":"2014","unstructured":"Chen H, Gao Y, Wu J, Chen Y, Chen B, Hu J, et al. Exploring therapeutic potentials of baicalin and its aglycone baicalein for hematological malignancies. Cancer Lett. 2014;354:5\u201311.","journal-title":"Cancer Lett"},{"key":"1490_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0014-2999(03)01378-5","volume":"465","author":"Y-C Shen","year":"2003","unstructured":"Shen Y-C, Chiou W-F, Chou Y-C, Chen C-F. Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol. 2003;465:171\u201381.","journal-title":"Eur J Pharmacol"},{"key":"1490_CR40","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s40263-017-0451-y","volume":"31","author":"Y Li","year":"2017","unstructured":"Li Y, Zhao J, H\u00f6lscher C. Therapeutic potential of baicalein in Alzheimer\u2019s disease and Parkinson\u2019s disease. CNS Drugs. 2017;31:639\u201352.","journal-title":"CNS Drugs"},{"key":"1490_CR41","doi-asserted-by":"publisher","first-page":"D1404","DOI":"10.1093\/nar\/gkae1037","volume":"53","author":"K Gao","year":"2025","unstructured":"Gao K, Liu L, Lei S, Li Z, Huo P, Wang Z, et al. HERB 2.0: an updated database integrating clinical and experimental evidence for traditional Chinese medicine. Nucleic Acids Res. 2025;53:D1404-d1414.","journal-title":"Nucleic Acids Res"},{"key":"1490_CR42","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1158\/1538-7445.AM2022-1529","volume":"82","author":"K Jain","year":"2022","unstructured":"Jain K, Bhattacharyya S, Sayed A, Standing D, Benich K, Umar S, et al. Role of bitter taste receptor in colon cancer. Cancer Res. 2022;82:1529\u20131529.","journal-title":"Cancer Res"},{"key":"1490_CR43","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/hed.28120","volume":"47","author":"K Wei","year":"2025","unstructured":"Wei K, Hill BL, Thompson JC, Miller ZA, Mueller A, Lee RJ, et al. Bitter taste receptor agonists induce apoptosis in papillary thyroid cancer. Head Neck. 2025;47:2101\u201313.","journal-title":"Head Neck"},{"key":"1490_CR44","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11010-018-3464-z","volume":"454","author":"LTP Martin","year":"2019","unstructured":"Martin LTP, Nachtigal MW, Selman T, Nguyen E, Salsman J, Dellaire G, et al. Bitter taste receptors are expressed in human epithelial ovarian and prostate cancers cells and noscapine stimulation impacts cell survival. Mol Cell Biochem. 2019;454:203\u201314.","journal-title":"Mol Cell Biochem"},{"key":"1490_CR45","doi-asserted-by":"publisher","DOI":"10.1103\/PhysRevE.85.016117","author":"G Bounova","year":"2012","unstructured":"Bounova G, de Weck O. Overview of metrics and their correlation patterns for multiple-metric topology analysis on heterogeneous graph ensembles. Phys Rev E. 2012. https:\/\/doi.org\/10.1103\/PhysRevE.85.016117.","journal-title":"Phys Rev E"},{"key":"1490_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-024-00333-9","volume":"10","author":"W Someya","year":"2024","unstructured":"Someya W, Akutsu T, Schwartz J-M, Nacher JC. Measuring criticality in control of complex biological networks. NPJ Syst Biol Appl. 2024;10:9.","journal-title":"NPJ Syst Biol Appl"},{"key":"1490_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59620-6","volume":"16","author":"Q Pan","year":"2025","unstructured":"Pan Q, Ding L, Hladyshau S, Yao X, Zhou J, Yan L, et al. ScMINER: a mutual information-based framework for clustering and hidden driver inference from single-cell transcriptomics data. Nat Commun. 2025;16:4305.","journal-title":"Nat Commun"},{"key":"1490_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-042821","volume":"11","author":"J Peng","year":"2021","unstructured":"Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, et al. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older Chinese adults: a secondary analysis of a nationwide cohort. BMJ Open. 2021;11:e042821.","journal-title":"BMJ Open"},{"key":"1490_CR49","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","volume":"397","author":"K Rahimi","year":"2021","unstructured":"Rahimi K, Bidel Z, Nazarzadeh M, Copland E, Canoy D, Ramakrishnan R, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625\u201336.","journal-title":"Lancet"},{"key":"1490_CR50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrd3480","volume":"10","author":"DC Swinney","year":"2011","unstructured":"Swinney DC, Anthony J. How were new medicines discovered? Nat Rev Drug Discov. 2011;10:507\u201319.","journal-title":"Nat Rev Drug Discov"},{"key":"1490_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116306","volume":"309","author":"L Zhao","year":"2023","unstructured":"Zhao L, Zhang H, Li N, Chen J, Xu H, Wang Y, et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. J Ethnopharmacol. 2023;309:116306.","journal-title":"J Ethnopharmacol"},{"key":"1490_CR52","first-page":"1","volume":"19","author":"X Wang","year":"2021","unstructured":"Wang X, Wang ZY, Zheng JH, Li S. TCM network pharmacology: a new trend towards combining computational, experimental and clinical approaches. Chin J Nat Med. 2021;19:1\u201311.","journal-title":"Chin J Nat Med"},{"key":"1490_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/rcm.10028","volume":"39","author":"K Peng","year":"2025","unstructured":"Peng K, Xu S, Li M, Li W, Zou Y, Guo M, et al. Strategies for reducing the homogenization phenomenon in the screening of key components in network pharmacology based on the detectability of components. Rapid Commun Mass Spectrom. 2025;39:e10028.","journal-title":"Rapid Commun Mass Spectrom"},{"key":"1490_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s44385-024-00003-9","volume":"2","author":"Q Liao","year":"2025","unstructured":"Liao Q, Zhang Y, Chu Y, Ding Y, Liu Z, Zhao X, et al. Application of artificial intelligence in drug-target interactions prediction: a review. NPJ Biomed Innov. 2025;2:1.","journal-title":"NPJ Biomed Innov"},{"key":"1490_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.09.006","author":"L Qiao","year":"2025","unstructured":"Qiao L, Huo X, Huang W, Wang Z, Ren Y, Liu Y, et al. Advances in high-throughput drug screening based on pharmacotranscriptomics. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.09.006.","journal-title":"J Adv Res"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01490-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01490-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:42:26Z","timestamp":1789958546000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01490-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01490-1","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"assertion":[{"value":"5 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"220"}}